Accuracy Assessment of a Novel Gas Detection Approach in Dyslipidemia Diagnosis

NCT06486857 · tracked via the Priya Life Science China tracker

Sponsor

Beijing Anzhen Hospital

Phase

Observational

Started

2024-07-01

Last updated

2024-07-05

Condition(s) studied

DyslipidemiasGas Detection Method

Investigational drug(s) / intervention(s)

a novel gas detection method for dyslipidemia screening

a novel gas detection method for dyslipidemia screening: Multidimensional Mass Spectrometry Technologies Based on Exhaled Metabolic Fingerprint Spectra for Dyslipidemia Detection

Study summary

This study aims to validate the feasibility and accuracy of a novel gas detection method for dyslipidemia screening by analyzing the lipid profile of human breath metabolites. It explores a simple, rapid, and non-invasive method for screening dyslipidemia. The application prospects of this method are broad; it can be used not only for early screening and monitoring of dyslipidemia in hospitals and communities, providing strong support for the prevention of cardiovascular diseases, but also for the routine monitoring and treatment effectiveness evaluation of patients with hyperlipidemia, offering a scientific basis for personalized treatment plans. This study not only has profound scientific value but also provides a theoretical basis for the development of subsequent new clinical testing methods.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: 1. Age ≥ 18 years 2. Voluntarily signed the informed consent form Exclusion Criteria: 1. Patients with lung cancer, asthma, chronic obstructive pulmonary disease, pulmonary cystic fibrosis, or acute respiratory distress syndrome 2. Women who are pregnant or breastfeeding 3. Patients with chronic kidney disease (GFR \< 60 ml/min) or cirrhosis 4. Individuals unable to cooperate with the collection of exhaled gas samples

Primary outcome measure(s)

accuracy of cholesterol testing — within 1 week day of sample collection

Trial sites (1)

Facility	City	Region	Status
Beijing Anzhen hospital	Beijing	Beijing Municipality

More Beijing Anzhen Hospital trials in China

Helium-free Magnetocardiography Guided Therapy for Stable Coronary Artery Disease - A Randomized Controlled Trial Recruiting

Early Intra-aortic Balloon Pump Use After Venoarterial Extracorporeal Membrane Oxygenation Recruiting

China Extracorporeal Life Support Registry Recruiting

Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly Recruiting

Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke Recruiting

Other trials for the same condition

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia Recruiting

Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a) Active, not recruiting

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography Recruiting

Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06486857 on ClinicalTrials.gov ↗ ← All trials in China